A federal appropriations bill will not include a bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.1 Jointly sponsored by Senator Dick Durbin, D-Illinois, and Senator Chuck Grassley, R-Iowa, the provision would have required list prices included in direct-to-consumer television advertising.
The provision was part of the Trump administration’s drug pricing blueprint, and had received support from both political parties.1 Both Durbin and Grassley took to social media after the provision failed to move forward, to comment on the outcome, expressing disappointment with fellow members of Congress.
Read Next
